Overall Abstract The CNPRC has maintained a pedigreed colony of Indian origin rhesus macaques for over 19 years. The SPF Pedigreed Indian origin rhesus colony includes both an SPF level 1 colony negative for Simian Retrovirus (SRV), Simian Immmunodeficiency Virus (SIV) and Simian T Cell Lymphotrophic Virus (STLV) Herpes B virus (B virus) and an SPF level 2 colony free of three additional viruses including include rhesus cytomegalovirus (RhCMV), simian foamy virus (SFV), and rhesus rhadinovirus (RRV). All colony animals have MHC typing for Mamu-A*01, Mamu-A*08, and Mamu-B*01 and the colony is managed to optimize genetic diversity. No additional animal recruitment necessary. This application will expand the percentage of SPF2 rhesus while maintaining the current overall colony size. The application proposes to evaluate the possible addition of Adeno-associated virus (AAV) and Lymphocryptovirus (LCV) to a subset of SPF2 animals and the addition of Mamu B*17 to the MHC typing panel. This application will continue to collect fecal microbiome and peripheral lymphoid cells as a biorepository for use by HIV/AIDS investigators. The four principal goals of this application are: Screen the current SPF2 colony to explore the potential for the addition of AAV and LCV to the excluded agents, or more simply for adding information about these infections to our database. Develop improved and expanded screening and confirmatory tests for detection of SPF agents to facilitate maintenance of the SPF colony. This work includes new assays for agents such as tuberculosis, which represents the first SPF agent. Evaluate addition of Mamu-B*17 to the currently tracked MHC alleles, Mamu-A*01, Mamu-A*08, and Mamu- B*01. Transition the colony pedigree analysis from the current microsatellite platform to the SNP panel and validate the proposed SNP panel with existing microsatellite data. Continue the collection and storage of microbiome and lymphocyte samples in the unique biorepository of SPF2 to facilitate future research projects investigating the interaction of HIV with the host microbiome and immune system.

Public Health Relevance

The CNPRC has a long history in the production of SPF rhesus macaques. The goal of this application is to continue and expand on the improvement and characterization of the model through a program of viral screening, genetic testing, characterization of the enteric microbiome.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Animal (Mammalian and Nonmammalian) Model, and Animal and Biological Materials Resource Cooperative Agreements (U42)
Project #
5U42OD010990-21
Application #
10101707
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Arnegard, Matthew Erin
Project Start
2000-09-30
Project End
2024-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
21
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of California Davis
Department
Veterinary Sciences
Type
Primate Centers
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Yee, JoAnn L; Grant, Richard; Van Rompay, Koen K et al. (2017) Emerging diagnostic challenges and characteristics of simian betaretrovirus infections in captive macaque colonies. J Med Primatol 46:149-153
Chang, W L William; Gonzalez, Denise F; Kieu, Hung T et al. (2017) Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques. PLoS One 12:e0170154
Yee, JoAnn L; Vanderford, Thomas H; Didier, Elizabeth S et al. (2016) Specific pathogen free macaque colonies: a review of principles and recent advances for viral testing and colony management. J Med Primatol 45:55-78
Oxford, Kristie L; Dela Pena-Ponce, Myra Grace A; Jensen, Kara et al. (2015) The interplay between immune maturation, age, chronic viral infection and environment. Immun Ageing 12:3
Yee, JoAnn L; Montiel, Nestor A; Ardeshir, Amir et al. (2013) Constitutive release of IFN? and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1. Comp Med 63:508-14